US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.610
  • -0.010-0.22%
Close Dec 13 16:00 ET
  • 4.640
  • +0.030+0.64%
Post 20:01 ET
268.80MMarket Cap-15.90P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-611.27%-14.58M
47.59%-6.93M
-76.20%7.57M
-59.98%12.8M
-139.63%-3.73M
-115.97%-2.05M
-332.54%-13.22M
686.04%31.8M
-50.19%31.98M
-64.61%9.42M
Net income from continuing operations
-3,986.13%-5.32M
-397.24%-4.52M
-227.49%-4.15M
-60.02%2.51M
-134.98%-2.4M
-95.81%137K
-40.95%1.52M
150.58%3.25M
-81.07%6.28M
-3.07%6.86M
Operating gains losses
----
----
----
--655K
--0
--0
--0
--655K
----
----
Depreciation and amortization
239.14%1.97M
226.91%1.97M
231.94%2.22M
10.14%3.01M
74.66%1.16M
-14.45%580K
-12.75%602K
-4.56%670K
-3.80%2.73M
-6.09%663K
Deferred tax
-213.16%-3.09M
-184.81%-1.23M
-112.21%-246K
-213.81%-1.29M
-1,894.72%-7.48M
248.56%2.73M
177.93%1.46M
-54.40%2.01M
-83.25%1.13M
-68.24%417K
Other non cash items
-47.95%483K
-29.39%519K
-42.20%641K
39.21%3.42M
-23.34%647K
45.68%928K
73.76%735K
100.91%1.11M
42.13%2.46M
66.80%844K
Change In working capital
-42.22%-9.64M
75.50%-4.61M
-68.34%6.98M
-112.30%-747K
309.04%2.82M
-192.12%-6.78M
-16,615.79%-18.83M
44,180.00%22.04M
121.92%6.07M
-110.35%-1.35M
-Change in receivables
-119.18%-830K
43.25%-5.16M
-129.06%-2.59M
35.08%-707K
-18.79%-4.84M
829.85%4.33M
-662.42%-9.1M
354.83%8.9M
55.89%-1.09M
-145.16%-4.07M
-Change in inventory
61.37%-214K
93.38%263K
-60.81%29K
82.79%-771K
62.21%-427K
68.65%-554K
133.75%136K
106.28%74K
-100.58%-4.48M
-1,367.53%-1.13M
-Change in prepaid assets
49.10%-3.66M
53.94%-1.3M
-84.30%1.78M
238.90%8.52M
108.59%7.19M
-275.12%-7.19M
-751.36%-2.82M
184.92%11.35M
-392.06%-6.14M
104.57%3.45M
-Change in payables and accrued expense
-67.50%-469K
196.76%3.14M
110.80%1.17M
-193.14%-10.98M
201.65%3.33M
-120.93%-280K
-1,160.13%-3.24M
-180.37%-10.79M
287.93%11.79M
-250.32%-3.28M
-Change in other working capital
-45.05%-4.47M
59.15%-1.55M
-47.33%6.59M
-46.67%3.19M
-166.21%-2.44M
-172.06%-3.08M
-253.35%-3.8M
1,499.44%12.51M
6.00%5.99M
1,507.86%3.68M
Cash from discontinued investing activities
Operating cash flow
-611.27%-14.58M
47.59%-6.93M
-76.20%7.57M
-59.98%12.8M
-139.63%-3.73M
-115.97%-2.05M
-332.54%-13.22M
686.04%31.8M
-50.19%31.98M
-64.61%9.42M
Investing cash flow
Cash flow from continuing investing activities
-65.87%12.06M
92.00%-15.26M
-109.73%-18.22M
-124.15%-12.06M
-158.05%-43.78M
262.22%35.33M
-1,208.21%-190.89M
1,623.67%187.29M
165.09%49.93M
390.13%75.43M
Net PPE purchase and sale
-570.83%-161K
-96.36%-108K
86.27%-7K
43.59%-383K
3.80%-253K
83.78%-24K
71.50%-55K
32.00%-51K
-23.01%-679K
-96.27%-263K
Net investment purchase and sale
-65.44%12.22M
92.86%-13.63M
-108.28%-15.51M
75.86%88.99M
-24.52%57.14M
263.44%35.35M
-1,225.36%-190.84M
1,612.32%187.35M
166.46%50.6M
392.65%75.69M
Net other investing changes
--0
---1.52M
---2.71M
---100.67M
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-65.87%12.06M
92.00%-15.26M
-109.73%-18.22M
-124.15%-12.06M
-158.05%-43.78M
262.22%35.33M
-1,208.21%-190.89M
1,623.67%187.29M
165.09%49.93M
390.13%75.43M
Financing cash flow
Cash flow from continuing financing activities
0
-79.32%734K
-41.88%605K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-79.32%734K
-41.88%605K
Cash from discontinued financing activities
Financing cash flow
----
----
----
--0
----
----
----
----
-79.32%734K
-41.88%605K
Net cash flow
Beginning cash position
-31.28%103.42M
-64.58%125.63M
0.58%136.29M
157.65%135.5M
268.30%183.66M
156.21%150.5M
425.82%354.64M
157.65%135.5M
-14.64%52.59M
-2.30%49.87M
Current changes in cash
-107.58%-2.52M
89.13%-22.19M
-104.86%-10.65M
-99.10%745K
-155.61%-47.52M
472.39%33.28M
-2,224.23%-204.11M
1,369.27%219.1M
1,025.25%82.64M
5,078.73%85.45M
Effect of exchange rate changes
155.74%68K
42.31%-15K
-131.11%-14K
-82.26%47K
-18.03%150K
-303.33%-122K
-132.91%-26K
178.95%45K
391.21%265K
281.19%183K
End cash Position
-45.02%100.97M
-31.28%103.42M
-64.58%125.63M
0.58%136.29M
0.58%136.29M
268.30%183.66M
156.21%150.5M
425.82%354.64M
157.65%135.5M
157.65%135.5M
Free cash flow
-610.80%-14.74M
47.00%-7.04M
-76.18%7.56M
-60.33%12.42M
-143.54%-3.99M
-116.34%-2.07M
-341.72%-13.28M
699.60%31.75M
-50.83%31.31M
-65.43%9.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -611.27%-14.58M47.59%-6.93M-76.20%7.57M-59.98%12.8M-139.63%-3.73M-115.97%-2.05M-332.54%-13.22M686.04%31.8M-50.19%31.98M-64.61%9.42M
Net income from continuing operations -3,986.13%-5.32M-397.24%-4.52M-227.49%-4.15M-60.02%2.51M-134.98%-2.4M-95.81%137K-40.95%1.52M150.58%3.25M-81.07%6.28M-3.07%6.86M
Operating gains losses --------------655K--0--0--0--655K--------
Depreciation and amortization 239.14%1.97M226.91%1.97M231.94%2.22M10.14%3.01M74.66%1.16M-14.45%580K-12.75%602K-4.56%670K-3.80%2.73M-6.09%663K
Deferred tax -213.16%-3.09M-184.81%-1.23M-112.21%-246K-213.81%-1.29M-1,894.72%-7.48M248.56%2.73M177.93%1.46M-54.40%2.01M-83.25%1.13M-68.24%417K
Other non cash items -47.95%483K-29.39%519K-42.20%641K39.21%3.42M-23.34%647K45.68%928K73.76%735K100.91%1.11M42.13%2.46M66.80%844K
Change In working capital -42.22%-9.64M75.50%-4.61M-68.34%6.98M-112.30%-747K309.04%2.82M-192.12%-6.78M-16,615.79%-18.83M44,180.00%22.04M121.92%6.07M-110.35%-1.35M
-Change in receivables -119.18%-830K43.25%-5.16M-129.06%-2.59M35.08%-707K-18.79%-4.84M829.85%4.33M-662.42%-9.1M354.83%8.9M55.89%-1.09M-145.16%-4.07M
-Change in inventory 61.37%-214K93.38%263K-60.81%29K82.79%-771K62.21%-427K68.65%-554K133.75%136K106.28%74K-100.58%-4.48M-1,367.53%-1.13M
-Change in prepaid assets 49.10%-3.66M53.94%-1.3M-84.30%1.78M238.90%8.52M108.59%7.19M-275.12%-7.19M-751.36%-2.82M184.92%11.35M-392.06%-6.14M104.57%3.45M
-Change in payables and accrued expense -67.50%-469K196.76%3.14M110.80%1.17M-193.14%-10.98M201.65%3.33M-120.93%-280K-1,160.13%-3.24M-180.37%-10.79M287.93%11.79M-250.32%-3.28M
-Change in other working capital -45.05%-4.47M59.15%-1.55M-47.33%6.59M-46.67%3.19M-166.21%-2.44M-172.06%-3.08M-253.35%-3.8M1,499.44%12.51M6.00%5.99M1,507.86%3.68M
Cash from discontinued investing activities
Operating cash flow -611.27%-14.58M47.59%-6.93M-76.20%7.57M-59.98%12.8M-139.63%-3.73M-115.97%-2.05M-332.54%-13.22M686.04%31.8M-50.19%31.98M-64.61%9.42M
Investing cash flow
Cash flow from continuing investing activities -65.87%12.06M92.00%-15.26M-109.73%-18.22M-124.15%-12.06M-158.05%-43.78M262.22%35.33M-1,208.21%-190.89M1,623.67%187.29M165.09%49.93M390.13%75.43M
Net PPE purchase and sale -570.83%-161K-96.36%-108K86.27%-7K43.59%-383K3.80%-253K83.78%-24K71.50%-55K32.00%-51K-23.01%-679K-96.27%-263K
Net investment purchase and sale -65.44%12.22M92.86%-13.63M-108.28%-15.51M75.86%88.99M-24.52%57.14M263.44%35.35M-1,225.36%-190.84M1,612.32%187.35M166.46%50.6M392.65%75.69M
Net other investing changes --0---1.52M---2.71M---100.67M------------------------
Cash from discontinued investing activities
Investing cash flow -65.87%12.06M92.00%-15.26M-109.73%-18.22M-124.15%-12.06M-158.05%-43.78M262.22%35.33M-1,208.21%-190.89M1,623.67%187.29M165.09%49.93M390.13%75.43M
Financing cash flow
Cash flow from continuing financing activities 0-79.32%734K-41.88%605K
Proceeds from stock option exercised by employees --------------0-----------------79.32%734K-41.88%605K
Cash from discontinued financing activities
Financing cash flow --------------0-----------------79.32%734K-41.88%605K
Net cash flow
Beginning cash position -31.28%103.42M-64.58%125.63M0.58%136.29M157.65%135.5M268.30%183.66M156.21%150.5M425.82%354.64M157.65%135.5M-14.64%52.59M-2.30%49.87M
Current changes in cash -107.58%-2.52M89.13%-22.19M-104.86%-10.65M-99.10%745K-155.61%-47.52M472.39%33.28M-2,224.23%-204.11M1,369.27%219.1M1,025.25%82.64M5,078.73%85.45M
Effect of exchange rate changes 155.74%68K42.31%-15K-131.11%-14K-82.26%47K-18.03%150K-303.33%-122K-132.91%-26K178.95%45K391.21%265K281.19%183K
End cash Position -45.02%100.97M-31.28%103.42M-64.58%125.63M0.58%136.29M0.58%136.29M268.30%183.66M156.21%150.5M425.82%354.64M157.65%135.5M157.65%135.5M
Free cash flow -610.80%-14.74M47.00%-7.04M-76.18%7.56M-60.33%12.42M-143.54%-3.99M-116.34%-2.07M-341.72%-13.28M699.60%31.75M-50.83%31.31M-65.43%9.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+24.43%
Taiwan Semiconductor
TSM
+4.98%
Tesla
TSLA
+4.34%
ASML Holding
ASML
+0.77%
Qualcomm
QCOM
+0.18%

Unlock the Full List